Small- and mid-cap stocks are expected to see a boost as the Federal Reserve cuts rates, and Oppenheimer named a few of its favorite plays on the space. Stocks with smaller market caps, which are more sensitive to higher costs of borrowing, are expected to rebound and outperform as the Fed embarks on a rate-cutting cycle. In 2024, the small-cap benchmark Russell 2000 's 8% rise still lags the S & P 500's roughly 19% gain.
mountain Cogent Communications in 2024 Health-care services stock Chemed is another one of Oppenheimer's favorites. Chemed has two segments: Vitas Healthcare, a hospice care provider company, and Roto-Rooter, a plumbing and drain cleaning company. This portfolio "offers an attractive mix of diversification and growth," according to analyst Michael Wiederhorn. Wiederhorn thinks Chemed is well-positioned to benefit from aging demographic trends.
المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »